ClinicalTrials.gov record
Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer
ClinicalTrials.gov ID: NCT00673049
Public ClinicalTrials.gov record NCT00673049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Open Label, Phase 3 Trial Of Erlotinib Alone Or In Combination With CP-751,871 In Patients With Advanced Non Small Cell Lung Cancer Of Non Adenocarcinoma Histology
Study identification
- NCT ID
- NCT00673049
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 583 participants
Conditions and interventions
Conditions
Interventions
- CP 751,871 (Figitumumab) Drug
- Erlotinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- Feb 28, 2011
- Completion
- Mar 31, 2012
- Last update posted
- Jul 23, 2013
2008 – 2012
United States locations
- U.S. sites
- 69
- U.S. states
- 23
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Fort Smith | Arkansas | 72903 | — |
| Pfizer Investigational Site | Hot Springs | Arkansas | 71913 | — |
| Pfizer Investigational Site | Lakeport | California | 95453 | — |
| Pfizer Investigational Site | Orange | California | 92868-3298 | — |
| Pfizer Investigational Site | Orange | California | 92868 | — |
| Pfizer Investigational Site | Petaluma | California | 94954 | — |
| Pfizer Investigational Site | Santa Rosa | California | 95403 | — |
| Pfizer Investigational Site | Thousand Oaks | California | 91360 | — |
| Pfizer Investigational Site | Westlake Valley | California | 91360 | — |
| Pfizer Investigational Site | Denver | Colorado | 80205 | — |
| Pfizer Investigational Site | Lafayette | Colorado | 80026 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Lake City | Florida | 32024 | — |
| Pfizer Investigational Site | Lake City | Florida | 32055 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Pfizer Investigational Site | Alpharetta | Georgia | 30005 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30308 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30322 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Conyers | Georgia | 30094 | — |
| Pfizer Investigational Site | Cumming | Georgia | 30041 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Duluth | Georgia | 30096 | — |
| Pfizer Investigational Site | Lake Spivey | Georgia | 30236 | — |
| Pfizer Investigational Site | Lawrenceville | Georgia | 30046 | — |
| Pfizer Investigational Site | Snellville | Georgia | 30078 | — |
| Pfizer Investigational Site | Bloomington | Illinois | 61701 | — |
| Pfizer Investigational Site | Peoria | Illinois | 61615 | — |
| Pfizer Investigational Site | Beech Grove | Indiana | 46107 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46237 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46260 | — |
| Pfizer Investigational Site | Cedar Rapids | Iowa | 52402 | — |
| Pfizer Investigational Site | Waterloo | Iowa | 50701 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40207 | — |
| Pfizer Investigational Site | Bethesda | Maryland | 20817 | — |
| Pfizer Investigational Site | New Albany | Mississippi | 38652 | — |
| Pfizer Investigational Site | Billings | Montana | 59102 | — |
| Pfizer Investigational Site | Butte | Montana | 59701 | — |
| Pfizer Investigational Site | Lebanon | New Hampshire | 03756 | — |
| Pfizer Investigational Site | Manchester | New Hampshire | 03102 | — |
| Pfizer Investigational Site | Amherst | New York | 14221 | — |
| Pfizer Investigational Site | Buffalo | New York | 14263 | — |
| Pfizer Investigational Site | Lake Success | New York | 11042 | — |
| Pfizer Investigational Site | Manhasset | New York | 11030 | — |
| Pfizer Investigational Site | New Hyde Park | New York | 11040 | — |
| Pfizer Investigational Site | The Bronx | New York | 10461 | — |
| Pfizer Investigational Site | The Bronx | New York | 10467 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43210 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43221 | — |
| Pfizer Investigational Site | Norman | Oklahoma | 73071 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73102 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73109 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73120 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74133 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Pfizer Investigational Site | Germantown | Tennessee | 38138 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | Charlottesville | Virginia | 22908-0334 | — |
| Pfizer Investigational Site | Charlottesville | Virginia | 22908-0716 | — |
| Pfizer Investigational Site | Gloucester | Virginia | 23601 | — |
| Pfizer Investigational Site | Glouster | Virginia | 23061 | — |
| Pfizer Investigational Site | Newport News | Virginia | 23601 | — |
| Pfizer Investigational Site | Williamsburg | Virginia | 23185 | — |
| Pfizer Investigational Site | Wenatchee | Washington | 98801 | — |
| Pfizer Investigational Site | Wheeling | West Virginia | 26003-6300 | — |
| Pfizer Investigational Site | Cody | Wyoming | 82414 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 106 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00673049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00673049 live on ClinicalTrials.gov.